focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Updated Appendix to Schedule 1

31 Aug 2012 15:49

RNS Number : 2663L
Phorm Inc
31 August 2012
 



 

31 August 2012

 

Phorm, Inc. ("Phorm" or the "Company")

 

Updated Appendix to Schedule 1 and Correction to Announcements

 

Further to the announcement of 13 August 2012 regarding the Company's re-domicile to Singapore, the Company announces that it has uploaded an updated Appendix to the AIM Schedule 1 to its website at www.phorm.com.

 

The updated Appendix includes the following amendments to the Additional Information on the Directors of the Company:

 

·; The inclusion of the directorships of the newly incorporated Phorm Corporation Limited and Phorm Redom Corporation;

·; The amendment to directorships of Mark Schneider, Lord Lamont and Andrew Croxson; and

·; The inclusion of additional information in relation to a past directorship of Kent Ertugrul, Hamburger Halt Limited.

 

Further to the announcement of 19 June 2012, and under Schedule 2(g) of the AIM Rules in relation to the past and present directorships of Andrew Croxson, the announcement omitted his present directorships of Phorm Advertising and Content SRL, PT Reklam Çözümleri Ticaret Ve Servis A.Ş.and Phorm Solutions Korea, Inc. and his past directorship of Ingenious Consulting Associates Limited.

 

In addition, further to the announcement of 1 December 2008, and under Schedule 2(g) of the AIM Rules in relation to the past and present directorships of Lord Lamont, the announcement omitted his present directorships of The British-Iranian Chamber of Commerce and JSST Securities Limited and his past directorships of The British Romanian Chamber of Commerce and Anglo Arabian Projects Limited, as well as Pacific Life Re Limited, Pacific Life Re Services Limited, Tartan Financial (UK), Tartan Holdings (UK) Limited and JFIT Securities Limited (each of which are subsidiaries of entities disclosed at that time).

 

In addition, further to the announcement of 16 August 2010, and under Schedule 2(g) of the AIM Rules in relation to the past and present directorships of Mark Schneider, the announcement omitted his present directorships of ShortsTV France Limited, Shorts International Limited and his past directorship of Music Choice Europe Limited.

 

 

For Enquiries

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

 

Hudson Sandler +44 20 7796 4133

Charlie Jack

Charlie Barker

 

- ends -

 

 

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALPFDLPAEFF
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.